Ardelyx, Inc. announced that Geoffrey Block, MD, is stepping down from the Board of Directors after nearly five years of service. Dr. Block currently serves as the Associate Chief Medical Director and Senior Vice President of Clinical Research and Medical Affairs at U.S. Renal Care.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
7.79 USD | -2.87% | -16.33% | +25.65% |
05-09 | Ardelyx Insider Sold Shares Worth $2,522,217, According to a Recent SEC Filing | MT |
05-09 | Ardelyx Insider Sold Shares Worth $1,831,503, According to a Recent SEC Filing | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+25.65% | 1.88B | |
+5.33% | 111B | |
+12.11% | 105B | |
-12.56% | 22.34B | |
-3.70% | 21.93B | |
-6.03% | 18.59B | |
-35.21% | 18.12B | |
-10.86% | 16.96B | |
+5.10% | 13.7B | |
+37.57% | 12.45B |
- Stock Market
- Equities
- ARDX Stock
- News Ardelyx, Inc.
- Ardelyx Announces Departure of Geoffrey Block as Board Member